Influenza: Cardiovascular Risks and Considerations During the COVID-19 Pandemic

Member Cost: $0Non-member Cost: $0
Credits: 0 CE contact hours, 0 CE pharmacology hours

Course Overview

Learn why the flu vaccine is especially important for individuals with a history of atherosclerotic cardiovascular disease (ASCVD) and stroke, as well as the complications associated with influenza. We’ll also discuss vaccine adherence strategies in the era of Covid-19 and provide practical clinical takeaways you can apply as we head into flu season this year.

Member Cost: $0Non-member Cost: $0
Credits: 0 CE contact hours, 0 CE pharmacology hours

Learning Objectives

  1. Describe the burden and potential complications of influenza
  2. Discuss the relationship between influenza and cardiovascular disease
  3. Discuss the impact of influenza vaccination as it relates to cardiovascular outcomes
  4. Highlight the various influenza vaccine options available
  5. Describe influenza immunization rates in adults, health disparities and identify opportunities for improvement
  6. Describe the relationship between COVID-19 and cardiovascular disease and summarize current immunization recommendations

Faculty

  • Eileen Handberg, Ph.D., ARNP
  • Christina Tankersley, PharmD

Full_Color_Provider

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of PCNA. PCNA is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030602.